GlobalGov › Germany › Solicitation

Germany – Pharmaceutical products

Original title (German): Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus (ATC-Code nach WHO: L04AD02), mit Einschränkung auf die Darreichung

AOK Plus - Die Gesundheitskasse Für Sachsen Und Thüringen · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

October 31, 2027
Response Due
Active
Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

This Germany Health Services opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agencyAOK Plus - Die Gesundheitskasse Für Sachsen Und Thüringen
CountryGermany
CategoryHealth Services
PublishedSeptember 14, 2026
Procurement stageRequest for Proposal (RFP)
Response dueOctober 31, 2027
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Browse all categories →

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Teduglutid (ATC-Code nach WHO: A16AX08)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Natalizumab (ATC-Code nach WHO: L04AG03)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brivaracetam (ATC-Code nach WHO: N03AX23)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Apixaban (ATC-Code nach WHO: B01AF02)
Germany – Architectural, engineering and planning services – Regelmäßige nichtverbindliche Bekanntmachung zur Fristverkürzung A&I
Germany – Engineering services – Technische Projekt- und Ingenieursleistungen
Germany – Security services – Regelmäßige nichtverbindliche Bekanntmachung zur Fristverkürzung SbaD
Germany – Agency fuel cards – Rahmenvereinbarung für die Versorgung von Fahrzeugen mit Kraftstoffen/Betriebsstoffen/Ladestrom, Betriebshilfsstoffen, Maut und fahrzeugbezogenen Serviceleistungen mittels Tankkarten in Europa

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.